Healthcare Transactions Under the Microscope: State and Federal Legislative Update

New legal requirements at both the federal and state level may impact the ability of healthcare investors and healthcare companies to execute on investment and growth transactions. Some recently passed state laws require advance notice and/or approvals for certain healthcare transactions, creating new potential hurdles to closing transactions and extending pre-closing timelines to account for applicable review periods. Proposed federal legislation, if passed, could impose new disclosure and operating requirements on healthcare investors and healthcare businesses.

Stay ahead of these new developments with our latest webinar breaking down what healthcare investors and healthcare providers need to know when it comes to new legal requirements impacting healthcare transactions. Topics to be discussed include:

• New state transaction notification and approval requirements and their application to healthcare companies and investors
• Overview of select proposed state and federal legislation, including recent updates regarding California’s AB 3129 that recently passed through the California House and Senate, and what this means for health industry stakeholders and future deals
• Proactive approaches to reduce potential transaction delays and mitigate investigation risk

Navigating and staying on top of these new requirements can be complicated, but McDermott is here to help you reach success while ensuring compliance with state and federal agencies.